• Share this page:

FDA Approves Cymbalta for Chronic Joint, Muscle Pain

(Yahoo! News) UPDATED 2010-11-05
The antidepressant Cymbalta (duloxetine hydrochloride) has been approved by the U.S. Food and Drug Administration for the treatment of chronic musculoskeletal pain from such conditions as osteoarthritis and lower back pain. Cymbalta has previously been approved to treat generalized anxiety disorder, fibromyalgia, and diabetic pain.   Read full story >
See all Rheumatoid Arthritis News